As the past decade barely dawned, a fundamentally novel view of cancer relating to signal transduction through intracellular hormones/growth factors and their subunits began to unfold. Further along, it gained additional substance with the advent of the interdisciplinary fields of particle biology and peptide strings which explain (onco)protein dynamics in spacetime, for instance insulin-driven sub-and trans-cellular carcinogenesis, by physical principles. Here, this new understanding is expanded to introduce the concept of "oncoprotein metastasis" preceding cancer cell spread and, thereby, a particular emphasis is placed on its potential role in the emergence of the pre-metastatic niche. Consistent with this perception, yet unlike currently advocated treatments that target cancer cells only, future antineoplastic strategies should aim to mimic natural tumor suppressors as well as involve both (morphologically) normal and malignant cells. If validated in human patients with advanced cancer disease, its otherwise frequently lethal course may be halted and reversed just in time.

